Evidence map›Paper›PMID 27981223›Full record

ArticleJAAD case reports2016

Malignant intertrigo: A subset of toxic erythema of chemotherapy requiring recognition.

Sabrina M Smith, Philip B Milam, Stephanie K Fabbro, Alejandro A Gru, Benjamin H Kaffenberger

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Toxic Flexural Epidermolysis in hospitalized patients.Archives of dermatological research · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Dermatologic conditions in women receiving systemic cancer therapy.International journal of women's dermatology · 2019
    Review
  8. Malignant intertrigo.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Article
  9. Recurrent candidal intertrigo: challenges and solutions.Clinical, cosmetic and investigational dermatology · 2018
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sabrina M SmithDepartment of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Philip B MilamDepartment of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Stephanie K FabbroDepartment of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Alejandro A GruDepartment of Pathology, University of Virginia, Charlottesville, Virginia.
Benjamin H KaffenbergerDepartment of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemotherapydrug eruptiongraft-versus-host diseaseintertrigoMI, malignant intertrigopathogenesisPPE, palmoplantar erythrodysesthesiaSDRIFE, symmetrical drug-related intertriginous, flexural exanthemaTEC, toxic erythema of chemotherapytoxic erythema of chemotherapy

Identifiers

PMID27981223
PMCPMC5149062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.